Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor of Musculoskeletal and Surgical Science, David Beard, has been awarded an Honorary Fellowship by the British Orthopaedic Association.

Horizontal portrait of David Beard

An Honorary Fellowship is the highest honour that the BOA (British Orthopaedic Association) can confer. It was awarded to Professor Beard in recognition of his outstanding contribution and achievements in research across the Trauma and Orthopaedic spectrum leading to improvements in patient care.

Professor Beard is one of the nominated Royal College of Surgeons (Eng) Surgical Trials chairs and Rosetrees Director of the Surgical Intervention Trials Unit (SITU-NDORMS) being responsible for a portfolio of surgical and complex intervention trials, many as co-applicant and some as Chief Investigator.

He is currently researching the introduction of robotic surgery in the NHS, surgical clinical trials methodology, including placebo control designs, and a host of musculoskeletal intervention efficacy studies. He is also involved in several international surgical trials and and supervises postgraduate students within NDORMS.

On being awarded the Honorary Fellowship, Professor Beard said;  

“I am very privileged and honoured to be given such a prestigious Fellowship by the BOA, especially in my core discipline, orthopaedic science. Like most personal awards the letters and certificate may point to a single name but it simply would not happen without the support and help from a set of first rate colleagues both in the Department and around the country.  To me it is very much a shared team award reflecting and recognising the success of orthopaedic/MSK research in Oxford (and the UK) over many years. Similar to everyone in NDORMS, I shall continue to do my very best research under the overall umbrella of improving healthcare, but it would give added satisfaction to see NDORMS remaining in the very top flight of those pursuing such an endeavour.” 

Similar stories

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Afsie Sabokbar wins Lifetime Achievement at Teaching Excellence Awards

Director of Graduate Studies Afsie Sabokbar wins Lifetime Achievement at 2021 Teaching Excellence Awards.

NDORMS staff recognised in the 2021 Teaching Excellence Awards

Director of Graduate Studies Afsie Sabokbar, Associate Professor Stephanie Dakin and Graduate Studies Officer Samuel Burnell were all winners in the Teaching Excellence Awards.

Five ways to take action for your bone health

On World Osteoporosis Day, the International Osteoporosis Foundation (IOF), the world’s largest non-governmental organisation in the bone field, urges action for osteoporosis and fracture prevention.

NDORMS researchers awarded funding by The Paget’s Association

Professor Philippa Hulley and Doctor Helen Knowles have been awarded funding by The Paget’s Association for their research on bone cells.